Consistent with our previous findings, IL-4 production was not enhanced by IL-12/ms treatment during primary infection, and IL-17 production was enhanced in all (re)infected mice regardless of IL-12/ms treatment (Fig. 5D). This evidence concerns the gene IL4 and infection.